Background Venovenous extracorporeal membrane oxygenation (ECMO) can be
considered for patients with COVID-19-associated acute respiratory distress syndrome …

Objective To summarize knowledge and identify gaps in evidence regarding treatment of
right ventricular dysfunction (RVD) in acute respiratory distress syndrome (ARDS). Data …

Extracorporeal membrane oxygenation (ECMO) has now been successfully delivered to
children 1 and young adults 2 for more than 50 years. ECMO is an invasive life support …

Disclosure: VZ is the chair and HY co-chair of the Protecting the Right Ventricle Network
(PRORVnet), with MVA, KS, and MS as members. VZ reports honoraria for education from …

Objective: Assessment of the results of the ProtekDuo cannula applied for dedicated right
ventricular support with oxygenator in ARDS secondary to COVID-19. Methods: Systematic …

Background Severe lung disease frequently presents with both refractory hypoxemia and
right ventricular (RV) failure. OxyRVAD is an extra-corporeal membrane oxygenation …

OBJECTIVES: To determine whether multisite versus single-site dual-lumen (SSDL)
cannulation is associated with outcomes for COVID-19 patients requiring venovenous …

The ProtekDuo is a single site, dual lumen cannula that may be used in a multitude of
configurations. 1 It was initially designed as right ventricular assist device (RVAD) cannula …

Background: Coronavirus disease 2019 (COVID-19) is the etiology of acute respiratory
distress syndrome (ARDS). Extracorporeal membrane oxygenation (ECMO) is used to …

Introduction Pulmonary vascular dysfunction during severe acute respiratory distress
syndrome (ARDS) may lead to right ventricle (RV) dysfunction and acute cor pulmonale …